Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints

Statistics in Medicine(2024)10.1002/sim.10282Source: DataRank Database

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints is a research paper published in Statistics in Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.54)OA: bronzeTopics (35)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Jian Wang ORCID,Jing Ning ORCID,Xinran Huang ORCID

Live enrichment

PubMed:39582325 PMC:PMC11645213 OpenAlex:https://openalex.org/W4404704073

National Cancer Institute

Grant: R01CA269696

National Cancer Institute

Grant: R01AI143886

National Cancer Institute

Grant: P50CA281701

Cancer Prevention and Research Institute of Texas

Grant: RP200633

FWCI

0.54

Citation Percentile

0.7%

Citation Trend

2025

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/sim.10282

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/sim.10282

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.10282

journalhttps://doi.org/10.1002/sim.10282

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39582325

Fields of Study

Statistical Methods in Clinical TrialsCancer Genomics and DiagnosticsOptimal Experimental Design Methods

MeSH Terms

Bayes TheoremComputer SimulationHumansNeoplasmsResearch DesignModels, StatisticalRandomized Controlled Trials as TopicClinical Trials, Phase II as TopicMedical FutilityEndpoint DeterminationEarly Termination of Clinical Trials

Keywords

Clinical endpointEvent (particle physics)Clinical trialSurrogate endpointClinical study designTime pointData monitoring committeeEndpoint DeterminationRandomized controlled trialBayesian probabilityMedicineComputer scienceStatisticsInternal medicineArtificial intelligenceMathematicsGibbs SamplingWin RatioTwo‐arm Phase Ii Clinical TrialBayesian Futility MonitoringMultiple Time‐to‐event Endpoints

Sustainable Development Goals

SDG 0: Good health and well-being